1183 related articles for article (PubMed ID: 30709370)
21. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
22. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.
Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ
Support Care Cancer; 2016 Jun; 24(6):2793-805. PubMed ID: 26984249
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: Laser in patients with head and neck cancer.
Dantas JBL; Martins GB; Lima HR; Carrera M; Reis SRA; Medrado ARAP
Spec Care Dentist; 2020 Jul; 40(4):364-373. PubMed ID: 32544269
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
25. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
Kia SJ; Basirat M; Saedi HS; Arab SA
BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
[TBL] [Abstract][Full Text] [Related]
26. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
27. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
28. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
29. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
Blakaj A; Bonomi M; Gamez ME; Blakaj DM
Oral Oncol; 2019 Aug; 95():29-34. PubMed ID: 31345391
[TBL] [Abstract][Full Text] [Related]
30. Effect of Honey-Lemon Spray Versus Benzydamine Hydrochloride Spray on Radiation-Induced Acute Oral Mucositis in Head and Neck Cancer Patients: A Pilot, Randomized, Double-Blind, Active-Controlled Clinical Trial.
Ameri A; Poshtmahi S; Heydarirad G; Cramer H; Choopani R; Hajimehdipoor H; Azghandi S; Pasalar M
J Altern Complement Med; 2021 Mar; 27(3):255-262. PubMed ID: 33512251
[No Abstract] [Full Text] [Related]
31. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
32. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
33. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
34. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
[TBL] [Abstract][Full Text] [Related]
35. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
36. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
37. Low-level Laser Therapy in the Management of Oral Mucositis Induced by Radiotherapy: A Randomized Double-blind Clinical Trial.
Kuhn-Dall'Magro A; Zamboni E; Fontana T; Dogenski LC; De Carli JP; Dall'Magro E; Fornari F
J Contemp Dent Pract; 2022 Jan; 23(1):31-36. PubMed ID: 35656654
[TBL] [Abstract][Full Text] [Related]
38. Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial).
Elsaadany B; Anayb SM; Mashhour K; Yossif M; Zahran F
BMC Oral Health; 2024 Jun; 24(1):645. PubMed ID: 38824583
[TBL] [Abstract][Full Text] [Related]
39. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
